glp-1 agonist fda approval just approved orforglipron (Foundayo), Eli Lilly's oral receptor for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest The FDA-approved GLP-1 pill for

Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-1/Smad signaling pathway, thereby leading to anti-fibrotic effect

For the capsule shells we use custom-made HPMC capsules that, unlike most other HPMC and pullulan capsules on the market, are 100% free from controversial additives such as carrageenans and PEG

Osteoporosis is a disease caused by progressive bone loss

Indirect Assessment of Mucosal Integrity by Potential Blood Biomarkers Both ex vivo and the direct in vivo tests for intestinal permeability are time and labor-intensive and are not readily available in most labs